Literature DB >> 20116231

The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients.

Luciana Paladini1, Rick Hodder, Isabella Cecchini, Vincenzo Bellia, Raffaele Antonelli Incalzi.   

Abstract

Dyspnoea is the most common symptom associated with poor quality of life in patients affected by Chronic Obstructive Pulmonary Disease (COPD). While COPD severity is commonly staged by lung function, the Medical Research Council (MRC) dyspnoea scale has been proposed as a more clinically meaningful method of quantifying disease severity in COPD. We wished to assess whether this scale might also be useful during telephone surveys as a simple surrogate marker of perceived health status in elderly patients with COPD. We conducted a comprehensive health status assessment by telephone survey of 200 elderly patients who had a physician diagnosis of COPD. The telephone survey contained 71 items and explored such domains as educational level, financial status, living arrangements and social contacts, co-morbid illness, and the severity and the impact of COPD on health status. Patients were categorized according to the reported MRC score: mild dyspnoea (MRC scale of 1), moderate dyspnoea (MRC scale of 2 and 3), or severe dyspnoea (MRC of 4 and 5). Deterioration in most of the recorded indicators of health status correlated with an increasingly severe MRC score. This was most evident for instrumental activities of daily living (IADL), perceived health and emotional status, pain-related limitations, limitations in social life, hospital admissions in preceding year and prevalence of most co-morbidities. The MRC dyspnoea scale is a reliable index of disease severity and health status in elderly COPD patients which should prove useful for remote monitoring of COPD and for rating health status for epidemiological purposes.

Entities:  

Mesh:

Year:  2010        PMID: 20116231     DOI: 10.1016/j.rmed.2009.12.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

1.  Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters.

Authors:  Neil Patel; John Belcher; Gary Thorpe; Nicholas R Forsyth; Monica A Spiteri
Journal:  Respir Res       Date:  2015-05-28

2.  Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting.

Authors:  Judith J Stephenson; Debra Wertz; Tao Gu; Jeetvan Patel; Anand A Dalal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-04

3.  Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD).

Authors:  Patrick Rockenschaub; Arnoupe Jhass; Nick Freemantle; Anna Aryee; Meena Rafiq; Andrew Hayward; Laura Shallcross
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

4.  Symptoms and impact of symptoms on function and health in patients with chronic obstructive pulmonary disease and chronic heart failure in primary health care.

Authors:  Kersti Theander; Mikael Hasselgren; Kristina Luhr; Jeanette Eckerblad; Mitra Unosson; Ingela Karlsson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-07-18

5.  Dyspnea in Chronic Fatigue Syndrome (CFS): comparison of two prospective cross-sectional studies.

Authors:  Murugan Ravindran; Oluwatoyin Adewuyi; Yin Zheng; Rakib U Rayhan; Uyenphuong Le; Christian Timbol; Samantha Merck; Rania Esteitie; Charles Read; Michelle Cooney; James Baraniuk
Journal:  Glob J Health Sci       Date:  2012-12-12

6.  Observational Real-World Study to Assess Clinical Characteristics and Device Satisfaction in Patients with COPD Treated with Glycopyrrolate/eFlow® CS.

Authors:  Judith J Stephenson; Carole Dembek; Amanda Caldwell-Tarr; Rebecca M Conto; Mark Paullin; Edward M Kerwin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.